These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8898434)

  • 1. Helicobacter pylori eradication: therapy other than with bismuth or proton-pump inhibitors.
    Korman MG
    Scand J Gastroenterol Suppl; 1996; 220():41-3. PubMed ID: 8898434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study).
    Treiber G; Wittig J; Ammon S; Walker S; van Doorn LJ; Klotz U
    Arch Intern Med; 2002 Jan; 162(2):153-60. PubMed ID: 11802748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Helicobacter pylori and peptic ulcer.
    Korman MG; Tytgat GN
    Scand J Gastroenterol Suppl; 1995; 210():92-6. PubMed ID: 8578219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sucralfate as an alternative to bismuth in quadruple therapy for Helicobacter pylori eradication.
    Korman MG; Bolin TD; Engelman JL; Pianko S
    Helicobacter; 1997 Sep; 2(3):140-3. PubMed ID: 9432342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [History of the treatment of Helicobacter pylori and clinical efficacy].
    Yamamoto I; Fukuda Y; Shimoyama T
    Nihon Rinsho; 1999 Jan; 57(1):32-42. PubMed ID: 10036933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of H2-receptor antagonist- and proton-pump inhibitor-based triple regimens for the eradication of Helicobacter pylori in Chinese patients with gastritis or peptic ulcer.
    Hu FL; Jia JC; Li YL; Yang GB
    J Int Med Res; 2003; 31(6):469-74. PubMed ID: 14708410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
    Laine L; Estrada R; Trujillo M; Emami S
    Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clarithromycin dual therapy regimens for eradication of Helicobacter pylori: a review.
    Pipkin GA; Dixon JS; Williamson R; Wood JR
    Helicobacter; 1997 Dec; 2(4):159-71. PubMed ID: 9421117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP2C19 genotype-related efficacy of omeprazole for the treatment of infection caused by Helicobacter pylori.
    Tanigawara Y; Aoyama N; Kita T; Shirakawa K; Komada F; Kasuga M; Okumura K
    Clin Pharmacol Ther; 1999 Nov; 66(5):528-34. PubMed ID: 10579481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ranitidine bismuth citrate-based triple therapy for seven days, with or without further anti-secretory therapy, is highly effective in patients with duodenal ulcer and Helicobacter pylori infection.
    Marchi S; Costa F; Bellini M; Belcari C; Mumolo MG; Tornar A; Spisni R; Torelli E; Maltinti G
    Eur J Gastroenterol Hepatol; 2001 May; 13(5):547-50. PubMed ID: 11396535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Eradication of Helicobacter pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2002].
    Buzás GM; Józan J
    Orv Hetil; 2004 Oct; 145(40):2035-41. PubMed ID: 15559530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-week ranitidine bismuth citrate in combinations with metronidazole, amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection: the RBC-MACH study.
    Sung JJ; Chan FK; Wu JC; Leung WK; Suen R; Ling TK; Lee YT; Cheng AF; Chung SC
    Aliment Pharmacol Ther; 1999 Aug; 13(8):1079-84. PubMed ID: 10468684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ranitidine bismuth citrate with clarithromycin alone or with metronidazole for the eradication of Helicobacter pylori.
    Bardhan KD; Morton D; Perry MJ; Sanders DS; Morris P; Rowland A; Thompson M; Mitchell TR; Roberts PM
    Aliment Pharmacol Ther; 2001 Aug; 15(8):1199-204. PubMed ID: 11472323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bismuth-based combination therapy for Helicobacter pylori-associated peptic ulcer disease (metronidazole for eradication, ranitidine for pain).
    Tefera S; Berstad A; Bang CJ; Nysaeter G; Hatlebakk JG; Olafsson S; Nesje LB; Hausken T; Berstad K; Hundal O
    Am J Gastroenterol; 1996 May; 91(5):935-41. PubMed ID: 8633584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Various durations of a standard regimen (amoxycillin, metronidazole, colloidal bismuth sub-citrate for 2 weeks or with additional ranitidine for 1 or 2 weeks) on eradication of Helicobacter pylori in Iranian peptic ulcer patients. A randomized controlled trial.
    Kaviani MJ; Malekzadeh R; Vahedi H; Sotoudeh M; Kamalian N; Amini M; Massarrat S
    Eur J Gastroenterol Hepatol; 2001 Aug; 13(8):915-9. PubMed ID: 11507355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Helicobacter pylori eradication therapy is more effective in peptic ulcer than in non-ulcer dyspepsia.
    Gisbert JP; Marcos S; Gisbert JL; Pajares JM
    Eur J Gastroenterol Hepatol; 2001 Nov; 13(11):1303-7. PubMed ID: 11692055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Helicobacter pylori-positive duodenal ulcer: three-day antibiotic eradication regimen.
    Catalano F; Branciforte G; Catanzaro R; Cipolla R; Bentivegna C; Brogna A
    Aliment Pharmacol Ther; 2000 Oct; 14(10):1329-34. PubMed ID: 11012478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Helicobacter pylori eradication: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics for 1 week-a meta-analysis of efficacy.
    Gisbert JP; González L; Calvet X; Roqué M; Gabriel R; Pajares JM
    Aliment Pharmacol Ther; 2000 Sep; 14(9):1141-50. PubMed ID: 10971230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis: proton pump inhibitor or H2-receptor antagonist for Helicobacter pylori eradication.
    Graham DY; Hammoud F; El-Zimaity HM; Kim JG; Osato MS; El-Serag HB
    Aliment Pharmacol Ther; 2003 May; 17(10):1229-36. PubMed ID: 12755836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel therapeutic approaches to the management of Helicobacter pylori infection.
    Montague S; O'Morain CA
    Ital J Gastroenterol Hepatol; 1998 Oct; 30 Suppl 3():S334-8. PubMed ID: 10077769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.